Effectiveness study of gemcitabine, oxaliplatin, and capecitabine as first-line treatment for nonresectable biliary tract cancer.
Lars Henrik Jensen
No relevant relationships to disclose
Anne Haahr Mellergaard
No relevant relationships to disclose
Dan Hoegdall
No relevant relationships to disclose
Ole Larsen
No relevant relationships to disclose